Excess Mortality During the COVID-19 Pandemic in Sonora, Mexico, 2015–2022: A Time-Series Analysis of Cause-Specific Mortality
Authors:
- Diego I. Álvarez-LópezDÁDiego I. Álvarez-López
- Elizabeth Ferreira-GuerreroEFElizabeth Ferreira-Guerrero
- Lina S. Palacio-MejíaLPLina S. Palacio-Mejía
- Amado D. Quezada-SánchezAQAmado D. Quezada-Sánchez
- Jorge Laureano-EugenioJLJorge Laureano-Eugenio
- Sergio Trujillo-LópezSTSergio Trujillo-López
- Mariann Duarte-BadilloMDMariann Duarte-Badillo
- Gerardo Álvarez-HernándezGÁGerardo Álvarez-Hernández
Open Access
- 28 July 2026
- journal article
- research article
- Published by MDPI AG in Epidemiologia
- Vol. 7 (4) , 105
Abstract
Background/Objectives: Excess mortality (EM) is a key indicator for assessing the population-level impact of large-scale health crises, particularly when cause-of-death ascertainment is incomplete or delayed. However, EM estimates are sensitive to methodological decisions, highlighting the need for operationally feasible approaches suitable for routine public health surveillance. Methods: We conducted time series analyses of routinely collected mortality data from a subnational setting in northern Mexico. Deaths recorded between 2015 and 2022 were grouped into 28 cause-of-death categories. Expected deaths during the COVID-19 pandemic period (March 2020–July 2022) were estimated using negative binomial regression models fitted to pre-pandemic data (2015–2019), incorporating a linear trend and monthly indicators to account for long-term trends and seasonality. Newey–West standard errors were used to address serial correlation and heteroskedasticity. EM was defined as the difference between observed and expected deaths. Results: An estimated 14,482 excess deaths were observed during the pandemic period, corresponding to a 30.9% increase relative to expected mortality. Time-series models identified four distinct peaks of excess mortality coinciding with major pandemic waves. Although COVID-19 accounted for most excess deaths, among non-COVID causes, only ischemic heart disease and diabetes showed statistically significant excess mortality among major non-communicable diseases after baseline adjustment. However, additional categories—including non-transport-related accidents, ill-defined causes, and other endocrine, metabolic, hematological, and immunological diseases—also exhibited statistically significant excess mortality. For several causes, increases in crude mortality did not translate into statistically significant excess mortality. Conclusions: Negative binomial time series regression provides an implementable framework for estimating EM, underscoring the importance of expected mortality estimation for understanding population-level mortality dynamics during health emergencies.Keywords
This publication has 29 references indexed in Scilit:
- Postpandemic Cardiac Mortality RatesJAMA Network Open, 2025
- Diabetes and deaths of COVID-19 patients: Systematic review of meta-analysesHealth Sciences Review, 2023
- The WHO estimates of excess mortality associated with the COVID-19 pandemicNature, 2022
- Leading causes of excess mortality in Mexico during the COVID-19 pandemic 2020–2021: A death certificates study in a middle-income countryThe Lancet Regional Health - Americas, 2022
- Impact of diabetes on COVID‐19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta‐analysisEndocrinology, Diabetes & Metabolism, 2022
- Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21The Lancet, 2022
- Significant association between ischemic heart disease and elevated risk for COVID-19 mortality: A meta-analysisThe American Journal of Emergency Medicine, 2022
- Emerging evidence for non-pharmacologic interventions in reducing the burden of respiratory illnessesInternal and Emergency Medicine, 2022
- Geographically weighted generalized Farrington algorithm for rapid outbreak detection over short data accumulation periodsStatistics in Medicine, 2021
- ${\tt surveillance}$ : An R package for the monitoring of infectious diseasesComputational Statistics, 2007